Planet 13 Holdings (PLNH) Acquisitions (2022 - 2023)
Planet 13 Holdings' (PLNH) quarterly Acquisitions came in at -$866250.0 in Q4 2023, down 5757.79% year-on-year from $15310.7 in Q4 2022, and down 200.0% on a QoQ basis from $866250.0 in Q1 2023.
Planet 13 Holdings (PLNH) Acquisitions (2022 - 2023) Analysis & Trends
Planet 13 Holdings (PLNH) has 2 years of Acquisitions data on file, last reported at -$866250.0 in Q4 2023.
- On a quarterly basis, Acquisitions fell 5757.79% year-over-year to -$866250.0 in Q4 2023; TTM through Sep 2024 was -$866250.0, a 201.74% decrease from a year earlier, with the FY2022 full-year figure at $1.5 million, changed N/A from the prior year.
- Acquisitions for Q4 2023 stood at -$866250.0, down from $866250.0 in the prior quarter.
- Over the last five years, Acquisitions for PLNH reached as high as $1.5 million in Q1 2022 and fell as low as -$866250.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -866,250.00 |
| Mar 31, 2023 | 866,250.00 |
| Dec 31, 2022 | -14,788.00 |
| Sep 30, 2022 | 15,224.00 |
| Mar 31, 2022 | 1.48 Mn |